Sartorius Stedim (France) Buy Hold or Sell Recommendation
| DIM Stock | EUR 203.40 4.90 2.35% |
Assuming the 90 days trading horizon and your above-average risk tolerance, our recommendation regarding Sartorius Stedim Biotech is 'Strong Sell'. Macroaxis provides Sartorius Stedim buy-hold-or-sell recommendation only in the context of selected investment horizon and investor attitude towards risk assumed by holding DIM positions. The advice algorithm takes into account all of Sartorius Stedim's available fundamental, technical, and predictive indicators you will find on this site. Key drivers impacting Sartorius Stedim's buy or sell advice are summarized below:
Real Value 198.57 | Hype Value 203.4 | Market Value 203.4 | Naive Value 191.19 |
A buy or sell recommendation provided by Macroaxis is an automated directive regarding whether to purchase or sell Sartorius Stedim Biotech given historical horizon and risk tolerance towards Sartorius Stedim. When Macroaxis issues a 'buy' or 'sell' recommendation for Sartorius Stedim Biotech, the advice is generated through an automated system that utilizes algorithms and statistical models.
Sartorius |
Execute Sartorius Stedim Buy or Sell Advice
The Sartorius recommendation should be used to complement the buy-or-sell advice compiled from the current analysts' consensus on Sartorius Stedim Biotech. Macroaxis does not own or have any residual interests in Sartorius Stedim Biotech or other equities on which the buy-or-sell advice is provided. Please provide your input below to execute Sartorius Stedim's advice using the current market data and latest reported fundamentals.
Time Horizon
Risk Tolerance
 |  |
Strong Sell
Market Performance | Very Weak | Details | |
Volatility | Very steady | Details | |
Hype Condition | Stale | Details | |
Current Valuation | Fairly Valued | Details | |
Odds Of Distress | Low | Details | |
Economic Sensitivity | Barely shadows the market | Details | |
Analyst Consensus | Not Available | Details | |
Reporting Quality (M-Score) | Inapplicable | Details |
Sartorius Stedim Trading Alerts and Improvement Suggestions
| Sartorius Stedim generated a negative expected return over the last 90 days | |
| About 74.0% of the company shares are held by company insiders |
Sartorius Stedim Returns Distribution Density
The distribution of Sartorius Stedim's historical returns is an attempt to chart the uncertainty of Sartorius Stedim's future price movements. The chart of the probability distribution of Sartorius Stedim daily returns describes the distribution of returns around its average expected value. We use Sartorius Stedim Biotech price's Value At Risk and its Upside Potential as a relative measure of the distribution. The graph of the distribution of Sartorius Stedim returns is essential to provide solid investment advice for Sartorius Stedim.
| Mean Return | -0.09 | Value At Risk | -3.11 | Potential Upside | 4.26 | Standard Deviation | 2.92 |
Return Density |
| Distribution |
Investment risk management requires an estimate of the probability of extreme price changes. Therefore, the correct representation of the distribution of Sartorius Stedim historical returns presented in an easy-to-digest graphical form helps investors and money managers understand the risk-reward trade-off of different investement strategies.
Sartorius Stedim Greeks
Most traded equities are subject to two types of risk - systematic (i.e., market) and unsystematic (i.e., nonmarket or company-specific) risk. Unsystematic risk is the risk that events specific to Sartorius Stedim or Healthcare sector will adversely affect the stock's price. This type of risk can be diversified away by owning several different stocks in different industries whose stock prices have shown a small correlation to each other. On the other hand, systematic risk is the risk that Sartorius Stedim's price will be affected by overall stock market movements and cannot be diversified away. So, no matter how many positions you have, you cannot eliminate market risk. However, you can measure a Sartorius stock's historical response to market movements and buy it if you are comfortable with its volatility direction. Beta and standard deviation are two commonly used measures to help you make the right decision.
α | Alpha over NYSE Composite | -0.06 | |
β | Beta against NYSE Composite | -0.51 | |
σ | Overall volatility | 2.86 | |
Ir | Information ratio | -0.06 |
Sartorius Stedim Volatility Alert
Sartorius Stedim Biotech exhibits very low volatility with skewness of -2.0 and kurtosis of 11.84. Understanding different market volatility trends often help investors to time the market. Properly using volatility indicators enable traders to measure Sartorius Stedim's stock risk against market volatility during both bullish and bearish trends. The higher level of volatility that comes with bear markets can directly impact Sartorius Stedim's stock price while adding stress to investors as they watch their shares' value plummet. This usually forces investors to rebalance their portfolios by buying different financial instruments as prices fall.Sartorius Stedim Fundamentals Vs Peers
Comparing Sartorius Stedim's fundamentals to the average values of its peers is one of the most widely used and accepted methods of equity analyses. It helps to analyze Sartorius Stedim's direct or indirect competition across all of the common fundamentals between Sartorius Stedim and the related equities. This way, we can detect undervalued stocks with similar characteristics as Sartorius Stedim or determine the stocks which would be an excellent addition to an existing portfolio. Peer analysis of Sartorius Stedim's fundamental indicators could also be used in its relative valuation, which is a method of valuing Sartorius Stedim by comparing valuation metrics with those of similar companies.
| Better Than Average | Worse Than Average | Compare Sartorius Stedim to competition |
| Fundamentals | Sartorius Stedim | Peer Average |
| Return On Equity | 0.41 | -0.31 |
| Return On Asset | 0.15 | -0.14 |
| Profit Margin | 0.25 % | (1.27) % |
| Operating Margin | 0.32 % | (5.51) % |
| Current Valuation | 31.28 B | 16.62 B |
| Shares Outstanding | 92.17 M | 571.82 M |
| Shares Owned By Insiders | 73.81 % | 10.09 % |
| Shares Owned By Institutions | 13.83 % | 39.21 % |
| Price To Earning | 80.53 X | 28.72 X |
| Price To Book | 13.32 X | 9.51 X |
| Price To Sales | 8.58 X | 11.42 X |
| Revenue | 3.49 B | 9.43 B |
| Gross Profit | 1.83 B | 27.38 B |
| EBITDA | 1.33 B | 3.9 B |
| Net Income | 1.13 B | 570.98 M |
| Cash And Equivalents | 161.7 M | 2.7 B |
| Cash Per Share | 1.75 X | 5.01 X |
| Total Debt | 1.02 B | 5.32 B |
| Debt To Equity | 0.50 % | 48.70 % |
| Current Ratio | 1.49 X | 2.16 X |
| Book Value Per Share | 26.58 X | 1.93 K |
| Cash Flow From Operations | 612.3 M | 971.22 M |
| Earnings Per Share | 9.52 X | 3.12 X |
| Price To Earnings To Growth | 3.36 X | 4.89 X |
| Target Price | 412.2 | |
| Number Of Employees | 11.93 K | 18.84 K |
| Beta | 0.45 | -0.15 |
| Market Capitalization | 28.45 B | 19.03 B |
| Total Asset | 5.07 B | 29.47 B |
| Retained Earnings | 462 M | 9.33 B |
| Working Capital | 122 M | 1.48 B |
| Current Asset | 439 M | 9.34 B |
| Current Liabilities | 317 M | 7.9 B |
Sartorius Stedim Market Momentum
Traders often use several daily momentume indicators to supplement a more traditional technical analysis when analyzing securities such as Sartorius . With many different options, investors must choose the best indicators for them and familiarize themselves with how they work. We suggest combining traditional momentum indicators with more near-term forms of technical analysis such as Accumulation Distribution or Daily Balance Of Power. With their quantitative nature, daily value technical indicators can also be incorporated into your automated trading systems.
About Sartorius Stedim Buy or Sell Advice
When is the right time to buy or sell Sartorius Stedim Biotech? Buying financial instruments such as Sartorius Stock isn't very hard. However, what challenging for most investors is doing it at the right time to beat the market. Proper market timing is something most people cannot do without sophisticated tools, which help to isolate the right opportunities. Macroaxis provides hands-on modules to deliver winning trades and diversify your portfolios on a daily basis. Most of our advising modules are very easy to use and apply.
Please read more on our stock advisor page.
Use Investing Ideas to Build Portfolios
In addition to having Sartorius Stedim in your portfolios, you can quickly add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your investment opportunity, you can then find an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility.Did You Try This Idea?
Run Latest Losers Thematic Idea Now
Latest Losers
Dynamically computed list of top equities currently sorted across major exchanges. The Latest Losers theme has 135 constituents at this time.
You can either use a buy-and-hold strategy to lock in the entire theme or actively trade it to take advantage of the short-term price volatility of individual constituents. Macroaxis can help you discover thousands of investment opportunities in different asset classes. In addition, you can partner with us for reliable portfolio optimization as you plan to utilize Latest Losers Theme or any other thematic opportunities.
| View All Next | Launch |
Check out Sartorius Stedim Analyst Recommendation to compare Macroaxis Buy or Sell Recommendation with the current analyst consensus. To check ratings for multiple equity instruments, please use the Instant Ratings tool. You can also try the Portfolio File Import module to quickly import all of your third-party portfolios from your local drive in csv format.
Complementary Tools for Sartorius Stock analysis
When running Sartorius Stedim's price analysis, check to measure Sartorius Stedim's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Sartorius Stedim is operating at the current time. Most of Sartorius Stedim's value examination focuses on studying past and present price action to predict the probability of Sartorius Stedim's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Sartorius Stedim's price. Additionally, you may evaluate how the addition of Sartorius Stedim to your portfolios can decrease your overall portfolio volatility.
| USA ETFs Find actively traded Exchange Traded Funds (ETF) in USA | |
| Portfolio Suggestion Get suggestions outside of your existing asset allocation including your own model portfolios | |
| Instant Ratings Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Bonds Directory Find actively traded corporate debentures issued by US companies | |
| Stock Tickers Use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites | |
| Portfolio Center All portfolio management and optimization tools to improve performance of your portfolios | |
| Aroon Oscillator Analyze current equity momentum using Aroon Oscillator and other momentum ratios | |
| Correlation Analysis Reduce portfolio risk simply by holding instruments which are not perfectly correlated |